Proceeds from the financing will be used to support the commercial expansion of Corus CAD, the only clinically validated gene expression test for obstructive coronary artery disease, and to develop additional genomic diagnostics in the field of cardiovascular disease.

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

600 Saginaw Dr.
Redwood City, CA 94063
USA

Phone

(650) 475-2788

Website

www.cardiodx.com

Email Address

[email protected]

Overview

CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, is committed to improving the quality of care for patients with cardiovascular disease through the research, development, and validation of clinically important genomic tests.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Khush Mehta

Chief Financial Officer

Timothy Henn

Chief Medical Officer

Mark Monane

VP - Bus. Development

Susan Daniels

VP - Bus. Development

David Levison

VP - R & D

James Wingrove

VP - Sales

Duane Williams

Browse more venture capital transactions:

Prev: 8/27/2012: Nasty Gal venture capital transaction
Next: 8/28/2012: Relay Foods venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary